Elevated serum epidermal growth factor receptor level in stage IV thymoma

Surgery Today

Volumn 34, Issue 5, 2004, Pages 477-479

  Sasaki, Hidefumi ^a   Yukiue, Haruhiro ^a   Sekimura, Atsushi ^a   Mizuno, Kotaro ^a   Konishi, Akimitsu ^a   Yano, Motoki ^a   Fukai, Ichiro ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Epidermal growth factor receptor; Invasive thymoma; Thymoma

Indexed keywords

BIOCHEMICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PREDICTION; PROTEIN BLOOD LEVEL; THYMOMA;

HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 2442619074     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2722-0     Document Type: Article

References (18)

1. Rusch V, Mendelsohn J, Dmitrovsky E. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev 1996;7:133-41.
2. Henley JD, Koukoulis GK, Loehrer PJ Sr. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002;128:167-70.
3. Hayashi Y, Ishii N, Obayashi C, Jinnai K, Hanioka K, Imai Y, et al. Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21. Virchows Arch 1995;426:43-50.
4. Parsons JT, Parsons SJ. Protein-tyrosine kinase, oncogenes and cancer. In: DeVita VT, Hellmann S, Rosenberg SA, editors. Important advances in oncology. Philadelphia: Lipincott-Raven; 1993. p. 3-18.
5. Gill G, Bertics P, Santon J. Epidermal growth factor and its receptor. Mol Cell Endocrinol 1994;51:169-86.
6. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
7. Ambs KE, Takahashi A, Hering F, Costa S, Huber PR. Epidermal growth factor receptor in adenocarcinoma of the kidney. Urol Res 1989;17:251-4.
8. Choi JH, Oh JY, Ryu SK, Kim SJ, Lee KY, Yi SY, et al. Detection of epidermal growth factor in the serum of gastric carcinoma patients. Cancer 1997;79:1879-93.
9. Partanen R, Hemminki K, Brandt-Rauf PW, Jin CG, Koskinen H. Serum levels of growth factor receptors, EGFR and Neu in asbestosis patients: a follow-up study. Int J Oncol 1994;4:1025-8.
10. Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW. The detection of increased amounts of extracellular domain of the epidermal growth factor in serum during carcinogenesis in asbestosis patients. J Occup Med 1994;36:1324-8.
11. Brand-Rauf PW. The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies. Mutat Res 1995;333:203-8.
12. Masaoka A, Monden Y, Nakahara K, Tanioka K. Follow up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
13. Gilhus NE, Jones M, Turley H, Gatter KC, Nagvekar N, Newsom-Davis J, et al. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen. J Clin Pathol 1995;48:447-55.
14. Modjtahedi H, Eccles S, Box G, Styles J, Dean C. Immunotherapy of human xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. Br J Cancer 1993;67:254-61.
15. Gilhus NE, Willcox N, Harcourt G, Nagvekar N, Beeson D, Vincent A, et al. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J Neuroimmunol 1995;56:65-76.
16. Sasaki H, Yukiue H, Mizuno K, Sekimura A, Konishi A, Yano M, et al. Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer. Int J Clin Oncol 2003;8:79-82.
17. Normanno N, De Luca A, Salomon DS, Ciardiello F. Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma. Cancer Detect Prev 1998;22:62-7.
18. Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1939 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 2000;6:4885-92.